Spira Avrum, Brecher Stephen, Karlinsky Joel
Department of Pulmonary and Critical Care Medicine, Boston University School of Medicine, Boston, Mass., USA.
Respiration. 2002;69(6):560-3. doi: 10.1159/000066467.
We describe the first case of pulmonary mucormycosis occurring in a patient with chronic obstructive pulmonary disease (COPD) maintained on chronic low dose oral steroids (10 mg/day). The diagnosis was made by direct histopathological examination and culturing of infected tissue obtained by fiberoptic bronchoscopy. Pulmonary mucormycosis is caused by infection with an opportunistic fungus of the order Mucorales and is an acute, rapidly developing and often fulminant process usually occurring in immunocompromised individuals. Risk factors include neutropenia, hematologic malignancies, uncontrolled diabetes mellitus, skin burns and deferoxamine therapy in dialysis patients. This case illustrates the importance of early suspicion of mucormycosis and immediate diagnostic bronchoscopic examination in cases of rapidly progressing pulmonary infiltrates in COPD patients on low doses of corticosteroids.
我们报告了首例发生在慢性阻塞性肺疾病(COPD)患者中的肺毛霉病病例,该患者长期服用低剂量口服类固醇(10毫克/天)。诊断通过对经纤维支气管镜获取的感染组织进行直接组织病理学检查和培养来确定。肺毛霉病由毛霉目机会性真菌感染引起,是一种急性、快速发展且通常呈暴发性的过程,常见于免疫功能低下的个体。危险因素包括中性粒细胞减少、血液系统恶性肿瘤、未控制的糖尿病、皮肤烧伤以及透析患者的去铁胺治疗。该病例说明了在低剂量皮质类固醇治疗的COPD患者出现快速进展的肺部浸润时,早期怀疑毛霉病并立即进行诊断性支气管镜检查的重要性。